270 related articles for article (PubMed ID: 22235061)
1. Suspected serotonin syndrome in a patient being treated with methylene blue for ifosfamide encephalopathy.
McDonnell AM; Rybak I; Wadleigh M; Fisher DC
J Oncol Pharm Pract; 2012 Dec; 18(4):436-9. PubMed ID: 22235061
[TBL] [Abstract][Full Text] [Related]
2. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.
Pelgrims J; De Vos F; Van den Brande J; Schrijvers D; Prové A; Vermorken JB
Br J Cancer; 2000 Jan; 82(2):291-4. PubMed ID: 10646879
[TBL] [Abstract][Full Text] [Related]
3. Methylene blue and ifosfamide-induced encephalopathy: Myth or reality?
Abahssain H; Moukafih B; Essangri H; Mrabti H; Meddah B; Guessous F; Fadhil FZ; Souadka A; Errihani H
J Oncol Pharm Pract; 2021 Jan; 27(1):143-149. PubMed ID: 33153383
[TBL] [Abstract][Full Text] [Related]
4. [Methylene blue in ifosfamide-induced encephalopathy].
Koschuth A; Späth-Schwalbe PE; Possinger K
Dtsch Med Wochenschr; 1996 Sep; 121(39):1210. PubMed ID: 8925751
[No Abstract] [Full Text] [Related]
5. Serotonin syndrome following methylene blue administration during cardiothoracic surgery.
Smith CJ; Wang D; Sgambelluri A; Kramer RS; Gagnon DJ
J Pharm Pract; 2015 Apr; 28(2):207-11. PubMed ID: 25613051
[TBL] [Abstract][Full Text] [Related]
6. Methylene blue encephalopathy: a case report and review of published cases.
Shopes E; Gerard W; Baughman J
AANA J; 2013 Jun; 81(3):215-21. PubMed ID: 23923673
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of ifosfamide induced encephalopathy with methylene-blue].
Ferrero JM; Eftekari P; Largillier R; Dreyfus G; Namer M
Bull Cancer; 1995 Jul; 82(7):598-9. PubMed ID: 7549123
[TBL] [Abstract][Full Text] [Related]
8. Serotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity With Methylene Blue.
Snyder M; Gangadhara S; Brohl AS; Ludlow S; Nanjappa S
Cancer Control; 2017; 24(5):1073274817729070. PubMed ID: 28975823
[TBL] [Abstract][Full Text] [Related]
9. Ifosfamide encephalopathy and methylene-blue: a case report.
Alonso JL; Nieto Y; López JA; Martín M; Díaz-Rubio E
Ann Oncol; 1996 Aug; 7(6):643-4. PubMed ID: 8879383
[No Abstract] [Full Text] [Related]
10. Methylene blue for ifosfamide-associated encephalopathy.
Zulian GB; Tullen E; Maton B
N Engl J Med; 1995 May; 332(18):1239-40. PubMed ID: 7700329
[No Abstract] [Full Text] [Related]
11. [Successful treatment with methylene blue of ifosfamide-induced central nervous system effects].
Demandt M; Wandt H
Dtsch Med Wochenschr; 1996 Apr; 121(17):575. PubMed ID: 8620831
[No Abstract] [Full Text] [Related]
12. Methylene blue for management of Ifosfamide-induced encephalopathy.
Patel PN
Ann Pharmacother; 2006 Feb; 40(2):299-303. PubMed ID: 16391008
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide-induced encephalopathy with or without using methylene blue.
Park IS; Lee HJ; Lee YS; Hwang JS; Lee MS
Int J Gynecol Cancer; 2005; 15(5):807-10. PubMed ID: 16174228
[TBL] [Abstract][Full Text] [Related]
14. Serotonin Toxicity and Urinary Analgesics: A Case Report and Systematic Literature Review of Methylene Blue-Induced Serotonin Syndrome.
Zuschlag ZD; Warren MW; K Schultz S
Psychosomatics; 2018 Nov; 59(6):539-546. PubMed ID: 30104021
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of (mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue.
Aeschlimann C; Cerny T; Küpfer A
Drug Metab Dispos; 1996 Dec; 24(12):1336-9. PubMed ID: 8971139
[TBL] [Abstract][Full Text] [Related]
16. [Ifosfamide induced encephalopathy: 15 observations].
Dufour C; Grill J; Sabouraud P; Behar C; Munzer M; Motte J; Oberlin O; Paci A; Hartmann O
Arch Pediatr; 2006 Feb; 13(2):140-5. PubMed ID: 16364615
[TBL] [Abstract][Full Text] [Related]
17. Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium.
Stanford SC; Stanford BJ; Gillman PK
J Psychopharmacol; 2010 Oct; 24(10):1433-8. PubMed ID: 19423610
[TBL] [Abstract][Full Text] [Related]
18. Myoclonus in patient on fluoxetine after receiving fentanyl and low-dose methylene blue during sentinel lymph node biopsy.
Larson KJ; Wittwer ED; Nicholson WT; Weingarten TN; Price DL; Sprung J
J Clin Anesth; 2015 May; 27(3):247-51. PubMed ID: 25499271
[TBL] [Abstract][Full Text] [Related]
19. The Use of Continuous Veno-Venous Hemodiafiltration in the Management of Ifosfamide-induced Encephalopathy: A Case Report.
Yeo KK; HaDuong JH
J Pediatr Hematol Oncol; 2016 Aug; 38(6):489-90. PubMed ID: 26907647
[TBL] [Abstract][Full Text] [Related]
20. Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy.
Küpfer A; Aeschlimann C; Cerny T
Eur J Clin Pharmacol; 1996; 50(4):249-52. PubMed ID: 8803513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
